Breath Predict is continuing to evaluate its respiratory technology through clinical research, with verified study information and evidence links published as they are confirmed.
Ongoing Oxford clinical trial
An NIHR-backed clinical trial is currently underway to expand the clinical evaluation of Breath Predict’s technology. Verified study details are published below as they are confirmed — no study information is stated ahead of verification.
Study
Oxford Clinical Trial
Research support
NIHR-backed
Status
Verified status to be added
Study reference
Clinical trial / publication link to be added
Clinically Validated Results
Proven in published clinical trials across adults and children
93%1
Diagnostic Accuracy
3 Days
Advance Attack Prediction
55%2
Reduction in Asthma Attacks
13
Breath Parameters Analysed
Research journey
How the evidence is being built
Breath Predict is building clinical evidence through a structured research journey, from early feasibility studies and clinical validation to ongoing Oxford-based research and future regulatory and clinical deployment.
Feasibility Research
Early evaluation of breath analysis across adults and children.
Confirmed date to be supplied
Clinical Validation
Expanding evaluation of diagnostic and predictive performance.
Confirmed date to be supplied
Ongoing Oxford Study
Oxford-based, NIHR-backed research currently underway.
Confirmed date to be supplied
Regulatory Development
Breath Predict is progressing through recognised regulatory pathways, including UKCA, CE/IVDR and FDA requirements.
Confirmed date to be supplied
Future Clinical Deployment
Integration into clinical and home monitoring pathways.
Confirmed date to be supplied
Lets Start Working Together
Like Nothing You’ve Seen. Contact Us Today & Experience New Diagnostic Solutions.